3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Soft Tissue Sarcoma Adult: new trials by email Literature Review of Soft Tissue Sarcoma Adult trials Research Report on Soft Tissue Sarcoma Adult
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study Association of Nivolumab + Relatlimab, Nivolumab - Soft Tissue Sarcoma Adult, Advanced Cancer | Phase 2 | Completed | Institut Bergonié | 68 | 2020-02-27 | 2026-04-21 |
| Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma Anlotinib Hydrochloride, Placebo Oral Tablet - Soft Tissue Sarcoma Adult, High Grade Sarcoma | Phase 2 | Completed | Fudan University | 88 | 2019-05-13 | 2025-05-14 |
| Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma Eribulin, Lenvatinib - Leiomyosarcoma, Liposarcoma | Phase 1 / Phase 2 | Completed | National Taiwan University Hospital | 30 | 2018-07-12 | 2025-12-05 |
Sarcoma (2) · Leiomyosarcoma (1) · Liposarcoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Tertiary Lymphoid Structures (1)
Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Muscle Tissue (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Nivolumab (1) · eribulin (1) · lenvatinib (1) · relatlimab (1)
Fudan University (1) · Institut Bergonié (1) · National Taiwan University Hospital (1)
China (1) · France (1) · Taiwan (1)
Wangjun Yan (1) · Wei-Wu Chen, MD (1)
2019 (1)